Effectiveness of sodium hyaluronate eye gel in patients with dry eye disease: A multi-centre, open label, uncontrolled study

Pakistan Journal of Medical Sciences

Volumn 29, Issue 4, 2013, Pages 1055-1058

  Saeed, Nasir ^a   Qazi, Za ^b   Butt, Nadeem H ^c   Siddiqi, Ahson ^d   Maheshwary, Neeta ^e   Athar Khan, Muhammad ^f  

^a Hayat Abad Medical Complex Peshawar ^*  (Pakistan)

^b LRBT Eye Hospital   (Pakistan)

^c JINNAH HOSPITAL   (Pakistan)

^d Head Medical and Regulatory Affairs   (Pakistan)

^e Medical Scientific Liaison (MSL) Novartis Pharma Pakistan   (Pakistan)

^f KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Fluorescein eye stain; Schirmer's test; Tear film break up time

Indexed keywords

HYALURONIC ACID;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY EYE; EPIPHORA; EYE BURNING; FEMALE; FOREIGN BODY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCULAR PRURITUS; OPEN STUDY; PAKISTAN; PHOTOPHOBIA; POSITIVE CORNEAL STAINING; SCHIRMER TEST; STAINING; TEAR FILM BREAKUP TIME; VISUAL SYSTEM EXAMINATION;

EID: 84879806255     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.294.3487     Document Type: Article

References (25)

1. Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea. 2006;25:1162-1167.
2. International Dry Eye Workshop (DEWS). The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surface. 2007;5:75-92.
3. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143(3):409-415.
4. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):93-107.
5. Munoz B, West SK, Rubin GS. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol 2000;118:819-25
6. Malik TA, Naqvi SAH, Shahid M. Dry eye syndrome; frequency in adult patients attending the eye clinic in Military hospital Rawalpindi. Professional Med J. 2009;16(1):145-158.
7. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001;286(17):2114-2119.
8. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318-326.
9. Han SB, Hyon JY, Woo SJ, Lee JJ, Kim T-H, Kim K-W. Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol. 2011;129:633-638.
10. Wang TJ, Wang IJ, Hu CC, Lin HC. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol. 2012;90(7):663-668.
11. Galor A, Feuer W, Lee DJ. Prevalence and risk factors of dry eye syndrome in a United States Veterans Affairs population. Am J Ophthalmol. 2011;152:377-384.
12. Milas M, Rinaudo M. Characterization and properties of hyaluronic acid (hyaluronan). In: Dumitriu S, ed. Polysaccharides Structural Diversity and Functional Versatility. New York, NY: Marcel Dekker; 2005:535-549.
13. Stuart JC, Linn JG. Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders. Ann Ophthalmol. 1985;17:190-192.
14. Fonn D. Targeting contact lens induced dryness and discomfort: what properties will make lenses more comfortable. Optom Vis Sci. 2007;84:279-285.
15. Lapcik L Jr, Lapcik L, De Smedt S. Hyaluronan: preparation, structure, properties, and applications. Chem Rev. 1998;98:2663-2684.
16. Troiano P, Monaco G. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study. Cornea. 2008;27(10):1126-1130
17. Pasquale AR, Vincenzo P, Antonio M, Marcello S, Giovanni M. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye.Br J Ophthalmol. 2002;86(2):181-184.
18. Lerner LE, Schawrtz DM, Hwang DG. Hyaluronan and CD44 in the human cornea and limbal conjunctiva. Exp Eye Res. 1998;67:481-484.
19. Baudouin F, Brignole F, Dupas B. Reduction in keratitis and CD44 expression in dry eye patients treated with a unique 0.18% sodium hyaluronate solution. Invest Ophthalmol Vis Sci. 2001;42:S32, abstract no 180.
20. Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol. 2005;243(6):531-538.
21. Takamura E, Tsubota K, Watanabe H, Ohashi Y. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Br J Ophthalmol. 2012;96(10):1310-1315.
22. Johnson ME, Murphy PJ, Boulton M. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch Clin Exp Ophthalmol. 2006;244:109-112.
23. Prabhasawat P, Tesavibul N, Kasetsuwan N. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study. Br J Ophthalmol. 2007;91:47-50.
24. Dumbleton K, Woods C, Fonn D. An investigation of the efficacy of a novel ocular lubricant. Eye Contact Lens. 2009;35:149-155.
25. Marjorie R. Hyaluronan: A Review of its Properties, Ophthalmic Uses and Research. Contact lens spectrum. 2010 April: 30-32.